NCT03057041

Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration

Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration: A Randomized Controlled Trial

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 107 (actual)
• Sponsor: University of Hawaii · Academic / Other
• Sex: Female
• Age: 14 Years
• Healthy volunteers: Accepted

Summary

Intranasal fentanyl has been found to be safe and effective in the reduction of pain among pediatric and adult populations. The investigators hypothesize that patients who receive 100 mcg of intranasal fentanyl for pain control before first-trimester uterine aspiration will report lower pain scores than those who receive placebo. The investigators will test this hypothesis using a randomized, double-blind, placebo-controlled trial comparing pain reported during uterine aspiration between patients who receive either intranasal fentanyl or intranasal saline prior to the procedure.

Conditions

• Pain Uterus

Interventions

Type	Name	Description
DRUG	Fentanyl	100 mcg of intranasal fentanyl, 50 mcg/ mL in each nostril via mucosal atomizer 15 minutes prior to procedure start
DRUG	placebo	1 mL of sterile saline in each nostril via mucosal atomizer 15 minutes prior to procedure start

Timeline

• Start date: 2017-03-23
• Primary completion: 2018-05-30
• Completion: 2018-05-30
• First posted: 2017-02-17
• Last updated: 2018-06-13

Locations

2 sites across 1 country: United States